Slides
Page 1
Pioneering WEE1 Inhibition to Deliver More Convenient , Targeted Cancer Care Corporate Presentation | August 2026 Nasdaq : ZNTL zentalis
Loading workspace
Pioneering WEE1 Inhibition to Deliver More Convenient , Targeted Cancer Care Corporate Presentation | August 2026 Nasdaq : ZNTL zentalis
Your watchlist and earnings event details are available after you sign in.